← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.91 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.90 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89 Optimized Temporal Window for Metabolic Boosting Therapy Det (IFNG) — 0.89 TREM2-APOE Axis Dissociation for Selective DAM Activation (TREM2-APOE axis) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.88 APOE-Dependent Autophagy Restoration (MTOR) — 0.88 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.87 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.87 Complement Cascade Inhibition Synaptic Protection (%s) — 0.87 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.87 Optogenetic restoration of hippocampal gamma oscillations vi (PVALB) — 0.87 Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated (PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway) — 0.87 Glymphatic-Mediated Tau Clearance Dysfunction (MAPT) — 0.86 Closed-loop focused ultrasound targeting EC-II PV interneuro (PVALB) — 0.86 TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima (NAMPT) — 0.86 TREM2-Mediated Microglial Dysfunction Disrupts Perivascular (TREM2) — 0.86 Circadian Glymphatic Entrainment via Targeted Orexin Recepto (HCRTR1/HCRTR2) — 0.86 RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA P (RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet) — 0.86
Add
|
× C1q-Conjugated miR-33 ASO × C1q-Mediated Delivery of
miR-33a/miR-33b · molecular biology · therapeutic
Composite 0.423
Price $0.44
Evidence For 0
Evidence Against 0
## Mechanistic Overview
C1q-Conjugated miR-33 ASO Brain Delivery for Enhanced APOE4 Lipidation starts from the claim that modulating miR-33a/miR-33b within the disease context of molecular biology can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview C1q-Conjugated miR-33 ASO Brain Delivery for Enhanced APOE4 Lipidation starts from the claim that modulating miR-33a/miR-33b within the disease context of molecular biology can redirect a disease-relevant
miR-33a/miR-33b · molecular biology · therapeutic
Composite 0.489
Price $0.50
Evidence For 0
Evidence Against 0
## Mechanistic Overview
C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides for Enhanced APOE4 Lipidation starts from the claim that modulating miR-33a/miR-33b within the disease context of molecular biology can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides for Enhanced APOE4 Lipidation starts from the claim that modulating miR-33a/miR-33b within the disease context of molecular biol
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
miR-33a miR-33b Biomarker Neuroinflammation molecular biology
Convergent signals
miR-33a recurs across 2 selected hypotheses with aligned directionality in biomarker, neuroinflammation.miR-33b recurs across 2 selected hypotheses with aligned directionality in biomarker, neuroinflammation.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 7/11
dimensions won
C1q-Conjugated miR-33 ASO Brain Delivery
5/11
dimensions won
C1q-Mediated Delivery of miR-33 Antisens
Radar Chart — 10 Dimensions
Score Breakdown
Dimension C1q-Conjugated miR-33 ASO Brai C1q-Mediated Delivery of miR-3 Mechanistic 0.760 0.700 Evidence 0.500 0.360 Novelty 0.400 0.000 Feasibility 0.370 0.000 Impact 0.410 0.000 Druggability 0.500 0.550 Safety 0.470 0.450 Competition 0.450 0.500 Data 0.400 0.700 Reproducible 0.580 0.650 KG Connect 0.122 0.122
Evidence C1q-Conjugated miR-33 ASO Brain Delivery for Enhanced APOE4 No evidence citations yet
C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides f No evidence citations yet
Debate Excerpts C1q-Conjugated miR-33 ASO Brain Delivery for Enhan 4 rounds · quality: 0.71
Theorist
# Mechanistic Hypotheses: APOE4 Cholesterol Synthesis Compensatory vs. Pathological
---
## Hypothesis 1: SREBP2 Cleavage Dysregulation by Unlipidated APOE4
**Mechanism:** APOE4's reduced lipid-bi...
Skeptic
# Critical Evaluation of APOE4 Cholesterol Synthesis Hypotheses
## Hypothesis 1: SREBP2 Cleavage Dysregulation by Unlipidated APOE4
### Strongest Specific Weakness: Mechanistic Incompatibility
Th...
Domain Expert
# Domain Expert Assessment: APOE4 Cholesterol Synthesis Hypotheses
## 1. Translational Potential Ranking
### Tier 1 (Highest Near-Term Potential): The Microglial Cholesterol-Mediated Neuroinflamma...
Synthesizer
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "Microglial Cholesterol Accumulation Driving NLRP3 Inflammasome Activation",
"mechanism": "APOE4 impairs microglial ABCA1/ABCG1...
C1q-Mediated Delivery of miR-33 Antisense Oligonuc 4 rounds · quality: 0.71
Theorist
# Mechanistic Hypotheses: APOE4 Cholesterol Synthesis Compensatory vs. Pathological
---
## Hypothesis 1: SREBP2 Cleavage Dysregulation by Unlipidated APOE4
**Mechanism:** APOE4's reduced lipid-bi...
Skeptic
# Critical Evaluation of APOE4 Cholesterol Synthesis Hypotheses
## Hypothesis 1: SREBP2 Cleavage Dysregulation by Unlipidated APOE4
### Strongest Specific Weakness: Mechanistic Incompatibility
Th...
Domain Expert
# Domain Expert Assessment: APOE4 Cholesterol Synthesis Hypotheses
## 1. Translational Potential Ranking
### Tier 1 (Highest Near-Term Potential): The Microglial Cholesterol-Mediated Neuroinflamma...
Synthesizer
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "Microglial Cholesterol Accumulation Driving NLRP3 Inflammasome Activation",
"mechanism": "APOE4 impairs microglial ABCA1/ABCG1...
Price History Overlay
Knowledge Graph Comparison
C1q-Conjugated miR-33 ASO Brain Delivery
2 edges
Top Node Types hypothesis 1
gene 1
Top Relations associated_with 1
targets 1
C1q-Mediated Delivery of miR-33 Antisens
2 edges
Top Node Types hypothesis 1
gene 1
Top Relations associated_with 1
targets 1